Skip to main content
OpenTrials
Completed

NCT Number: NCT04279730

Fatigue and Physical Performance During Pulmonary Rehabilitation

Patients with COPD benefit from pulmonary rehabilitation (PR), but a ceiling effect of performance (ie. absence of additional exercise tolerance increase) is observed in 80% of patients from only 20 sessions. An imbalance between intensity, duration and frequency of PR sessions, leading to fatigue development in the course of the PR, could explain this ceiling effect. However, previous studies having evaluated the impact of a PR program on fatigue scores reported either a decrease or no changing, but never an increase. To date, no study has evaluated intermediate variations of fatigue score during a PR program, but were limited to a pre-post PR assessment. Therefore, fatigue fluctuations during PR are unknown. Furthermore, most studies had only unidimensional fatigue assessment. Since fatigue is a multifactorial and a multidimensional process, it cannot be accurately estimated through a unique assessment. Given that most of COPD patients do not increase their exercise tolerance from 20 PR sessions, the investigators hypothesize a significant increase of multidimensional fatigue score between the 1st and the 20th PR session during an inpatient rehabilitation program lasting 4 weeks (40 sessions).

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Clinique du Souffle La Vallonie, Lodève, France

Loading trial locations.

About this study

Exercise tolerance is an important predictor of health status in patients with chronic obstructive pulmonary disease (COPD). A reduced 6-min walking distance is associated with an increased mortality risk in these patients. Pulmonary rehabilitation (PR) is one of the most efficient strategy to counterac this effect. Patients improving their exercise tolerance after a PR program have a reduced mortality risk. However, exercise tolerance improvement is not systematic after PR, since up to 1/3 of patients do not respond to the intervention. In addition, PR's effects are limited, with a ceiling effect of performance observed in 80% of patients from 20 sessions.

Fatigue could be one candidate to explain the ceiling effect of physical performance during PR. From a theoritical point of view, national and international guidelines on PR have continuously broadened PR interventions for the last 20 years, by progressively introducing in addition to endurance training, resistance training of the lower and then the upper limbs, electrical stimulation, stretching, respiratory muscle training... From a practical point of view, several patients complain of fatigue during PR. However, previous studies having evaluated the impact of a PR program on fatigue scores reported either a decrease or no changing, but never an increase. To date, no study has evaluated intermediate variations of fatigue score during a PR program, but were limited to a pre-post PR assessment. Therefore, fatigue fluctuations during PR are unknown. Furthermore, most studies had only unidimensional fatigue assessment. Since fatigue is a multifactorial and a multidimensional process, it cannot be accurately estimated through a unique assessment. Mutdimensional questionnaires and complementary indicators such as heart rate variability or visuomotor reaction time could be introduced.

Given that most of COPD patients do not increase their exercise tolerance from 20 PR sessions, the investigators hypothesize a significant increase of multidimensional fatigue score between the 1st and the 20th PR session during an inpatient rehabilitation program lasting 4 weeks (40 sessions).

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients admited for a 4-weeks inpatient pulmonary rehabilitation program
  • With a confirmed diagnosis of COPD

Exclusion criteria

  • Severe or unstable heart disease
  • Orthopedic, neurologic or psychatric comorbities
  • Recent exacerbation (<4 weeks)

Treatment and study plan

Primary outcomes

  1. Multidimensional fatigue score

    Time frame: Baseline (T0), 1st week (T1), 2nd week (T2), 3rd week (T3) and 4th week (T4) of the PR program

    Change in total fatigue score measured with the MFI-20 questionnaire

Secondary outcomes

  1. 6-min walking distance

    Time frame: Baseline (T0), 1st week (T1), 2nd week (T2), 3rd week (T3) and 4th week (T4) of the PR program

    Change in walking distance during a 6-min period over a corridor of 30m length

  2. Heart rate variability

    Time frame: Baseline (T0), 1st week (T1), 2nd week (T2), 3rd week (T3) and 4th week (T4) of the PR program

    Change in SDNN and RMSSD indices of RR intervals during a 5-min resting period and at exercise during a 6-min walking test

  3. Visuomotor reaction time

    Time frame: Baseline (T0), 1st week (T1), 2nd week (T2), 3rd week (T3) and 4th week (T4) of the PR program

    Change in the mean of 15 reaction time in response to visual stimuli

  4. Correlation between fatigue and physical performance

    Time frame: Baseline (T0), 1st week (T1), 2nd week (T2), 3rd week (T3) and 4th week (T4) of the PR program

    Change in the strength of the correlation between indicators of fatigue (muldimensional score, heart rate variability, visuomotor reaction time) and 6-min walking distance

Other outcomes

  1. Physical activity

    Time frame: During the 4 weeks of the PR program (continuous measurement)

    Measurement of physical activity via a triaxial accelerometer

  2. Daily subjective fatigue

    Time frame: Every morning of the 4 weeks PR program

    Fatigue evaluated by the patient every morning with a visual analogic scale

Sponsors and collaborators

Lead sponsor

5 Santé

Other

Collaborators

  • Ministry of Health, France

Registry information

Official study title

Impact of Fatigue on Physical Performance During a Pulmonary Rehabilitation Program in Patients With COPD

Acronym: PROMOD

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Feb 21, 2020
Registry last updated
Nov 14, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.